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Abstract
Background: Stable severe chronic obstructive pulmonary disease (COPD)
patients with chronic hypercapnic respiratory failure treated by nocturnal bi-
level positive pressure non-invasive ventilation (NIV) may experience severe
morning deventilation dyspnea. We hypothesised that in these patients,
progressive hyperinflation, resulting from inappropriate ventilator settings, leads
to patient-ventilator asynchrony (PVA) with a high rate of unrewarded inspiratory
efforts and morning discomfort. Methods: Polysomnography (PSG), diaphragm
electromyogram and transcutaneous capnography (PtcCO2) under NIV during
two consecutive nights using baseline ventilator settings on the first night,
then, during the second night, adjustment of ventilator parameters under PSG
with assessment of impact of settings changes on sleep, patient-ventilator
synchronisation, morning arterial blood gases and morning dyspnea. Results:
Eight patients (61 ± 8 years, FEV1 30 ± 8% predicted, residual volume 210 ±
30% ...
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Abstract
Background Stable severe chronic obstructive pulmonary
disease (COPD) patients with chronic hypercapnic respira-
tory failure treated by nocturnal bi-level positive pressure
non-invasive ventilation (NIV) may experience severe
morning deventilation dyspnea. We hypothesised that in
these patients, progressive hyperinflation, resulting from
inappropriate ventilator settings, leads to patient–ventilator
asynchrony (PVA) with a high rate of unrewarded inspira-
tory efforts and morning discomfort.
Methods Polysomnography (PSG), diaphragm electromyo-
gram and transcutaneous capnography (PtcCO2) under NIV
during two consecutive nights using baseline ventilator settings
on the first night, then, during the second night, adjustment of
ventilator parameters under PSG with assessment of impact of
settings changes on sleep, patient–ventilator synchronisation,
morning arterial blood gases and morning dyspnea.
Results Eight patients (61±8 years, FEV1 30±8% predicted,
residual volume 210±30% predicted) were included. In all
patients, pressure support was decreased during setting adjust-
ments, as well as tidal volume, while respiratory rate increased
without any deleterious effect on nocturnal PtcCO2 or morning
PaCO2. PVA index, initially high (40±30%) during the
baseline night, decreased significantly after adjusting ventilator
settings (p=0.0009), as well as subjective perception of PVA
leaks, and morning dyspnea while quality of sleep improved.
Conclusion The subgroup of COPD patients treated by
home NIV, who present marked deventilation dyspnea and
unrewarded efforts may benefit from adjustment of venti-
lator settings under PSG or polygraphy.
Keywords Non-invasive ventilation . COPD . Patient–
ventilator asynchrony
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EMG Electromyogram
EPAP Expiratory positive airway pressure
I/E ratio Inspiratory/expiratory ratio
IPAP Inspiratory positive airway pressure
kHz Kilohertz
kPa Kilopascals
MAI Microarousal index
NIV Non-invasive ventilation
PaCO2 Arterial partial pressure of carbon dioxide
PEEP Positive end-expiratory pressure
PEEPI Intrinsic positive end-expiratory pressure
PSG Polysomnography
PtcCO2 Transcutaneous measurement of arterial partial
pressure of carbon dioxide
PVA Patient–ventilator asynchrony
RR Respiratory rate
SE Sleep efficiency
SpO2 Oxygen saturation of Haemoglobin measured by
pulsoximetry
TIMAX Maximal inspiratory time
TST Total sleep time
VE Minute ventilation
VT Tidal volume
WASO Wake after sleep onset
Introduction
Despite the lack of evidence to support its use in
chronic obstructive pulmonary disease (COPD), non-
invasive ventilation (NIV) is widely prescribed in this
indication in Europe [1]. Although impact on survival
remains controversial [2–4], most authors will agree that
there appears to be a group of COPD patients who clearly
benefit from NIV. Indeed, several studies have described
improvements in health-related quality of life [3, 5, 6],
hospital admissions [7, 8], dyspnea [6] and quality of
sleep [5].
Recent reviews have stressed the importance of
identifying abnormal events occurring under NIV, and
adjusting ventilator settings accordingly [9]. For in-
stance, it is now established that patient–ventilator
asynchrony (PVA) is frequent in patients undergoing
chronic NIV who are considered effectively treated [10,
11]. PVA has a negative impact on quality of sleep and
potentially on treatment efficacy [10]. Monitoring pulse
oximetry (SpO2) and transcutaneous capnography
(PtcCO2) alone do not explore this aspect of therapy
adequately. Thus, in selected cases, polygraphy or poly-
somnography (PSG) might be ideal monitoring tools in
addition to oxy-capnography for patients with home
ventilation [12].
Among severe COPD under home NIV, patients are
occasionally burdened by a severe dyspnea when interrupt-
ing their treatment after a night of NIV. We hypothesised
that in these patients, inappropriate ventilator settings may
lead to dynamic hyperinflation, increased intrinsic PEEP,
resulting in unrewarded inspiratory efforts [13, 14] and
morning discomfort when interrupting NIV [15]. We
surmised that adjusting ventilator settings accordingly,
during PSG under NIV, might improve quality of sleep,
patient–ventilator synchronisation and morning dyspnea
(‘deventilation dyspnea’).
Materials and methods
Patients
Eligible patients fulfilled the following inclusion crite-
ria: (1) Severe COPD according to GOLD guidelines
[16], (2) home NIV initiated according to prevailing
recommendations [17], (3) stable clinical condition de-
fined as absence of exacerbation and of modifications of
ventilator settings in the month preceding the study, (4)
compliance to NIV of more than 4 h/day assessed by
ventilator software, (5) presence of deventilation dyspnea
defined as severe dyspnea occurring immediately after
interruption of non-invasive ventilation and preventing the
patient from getting out of bed and carrying out usual
daily activities for more than 30 min after one night of
NIV. Severe morning dyspnea was assessed by a chest
therapist using a modified Borg scale. All patients with
morning dyspnea score >4 were proposed to enter the
study. Exclusion criteria were: (1) use of NIV in an
acute exacerbation of COPD for hypercapnic ventilatory
failure, (2) association of COPD with restrictive thoracic
disorders (i.e. morbid obesity, cyphoscoliosis, neuromus-
cular disease, sequelae of tuberculosis), and (3) patients
under 18 years old or not able to give informed
consent.
Measurements
Polysomnography
Conventional polysomnography with patient under NIV
included: standard electroencephalography (seven elec-
trodes, F4–F3, O1–O2, C3–C4, Cz), left and right electro-
oculography, submental electromyography (EMG),
measurement of airflow using a pneumotachograph, body
position, thoracic and abdominal movements (Remlogic
1.1, Embla, Netherlands) and video recording. SpO2 was
measured continuously with a pulse oximeter and a finger
probe. PtcCO2 measurements were performed using a
1082 Sleep Breath (2012) 16:1081–1090
transcutaneous capnograph with an ear probe heated at 43°
C (Tosca 500, Radiometer, Switzerland). Sleep was scored
according to standard criteria using 30-s epochs [18]. The
investigator scoring the sleep study was blinded to the
ventilator settings and subjective evaluation. The follow-
ing sleep parameters were quantified: total sleep time
(TST), sleep efficiency (SE—TST/total recording time×
100), percentage of each sleep stage, wake after sleep
onset (WASO) and sleep latency. As indices of sleep
fragmentation, we considered the index of micro-arousals
(MAI). MAI were defined as a return to alpha or fast
frequency, well-differentiated from the background EEG
activity lasting >1.5 s.
Diaphragm EMG
Surface diaphragm EMG was recorded using silver electro-
des in all subjects only to monitor inspiratory effort [19]
and facilitate detection of ineffective inspiratory efforts.
The electrodes were placed in the right and left anterior
axillary line in the seventh intercostal space with a
horizontal distance of 2 cm. Diaphragmatic EMG was
sampled at 0.2 kHz, bandpass-filtered between 10 and
70 Hz [20] and recorded with all other parameters on the
Embla recording system.
Patient–ventilator asynchrony
Patterns of patient–ventilator asynchrony included inef-
fective triggering (unrewarded inspiratory efforts),
double-triggering and auto-triggering, as defined by
Thille et al. [13]. Unrewarded inspiratory efforts were
identified as the occurrence of a definite diaphragmatic
EMG signal, and/or presence of inspiratory thoracoabdo-
minal movements on strain gauges without subsequent
pressurisation by the ventilator. Auto-triggering was
defined as a cycle delivered by the ventilator and not
triggered by the patient. An unrewarded effort index was
calculated as follows: [number of desynchronized cycles/
total respiratory rate (i.e. cycles supported by the ventila-
tor plus unrewarded efforts)]×100 (expressed as a per-
centage) [21]. Only epochs (3 min.) with an unrewarded
effort index above 10% were scored as periods with
asynchrony based on a study by Vittaca and al. [22]. PVA
index was calculated as the ratio of total sleep time spent
with unrewarded efforts on TST [10].
Ventilator built-in software
Compliance, estimated tidal volume (VT), minute venti-
lation (VE), respiratory rate (RR), leaks and percent (%) of
spontaneous inspirations were downloaded after both
nights from built-in software of bi-level ventilators
(ResScan software, version 1.3, ResMed, Sydney, Aus-
tralia). Estimation of leaks and VT by ventilator software
of VPAP III and VPAP IV ventilators (ResMed, Sydney,
Australia) has been shown to be reliable in two recent
independent studies [23, 24].
Questionnaires
After both nights, to evaluate patient comfort and
patients’ perception of patient–ventilator synchronisa-
tion, airflow, leaks and noise of ventilator, an eight-item
visual analogue scale (VAS) was administered the
morning following each sleep study [25]. Higher values
indicate better comfort. Patients were also asked to
quantify their dyspnea on a visual analogue scale while
withdrawing from pressure support in the morning (10—
worst dyspnea ever experienced in the morning, 0—no
dyspnea at all).
Study protocol
Patients were admitted to the sleep laboratory for two
consecutive nights. On the first night, ventilator settings
were those normally used by the patient, thus eliminat-
ing the need of an accommodation night. This first
night aimed to detect and quantify PVA in highly
symptomatic COPD patients on their usual NIV set-
tings. In our institution, ventilation settings are adjusted
by chest therapists, under the supervision of the
attending pulmonary physician, aiming at patient com-
fort and optimal control of daytime and nocturnal SpO2
and PtcCO2. On the second night, the therapeutic target
was to reduce sleep-disordered breathing and patient–
ventilator asynchrony. The investigators adjusted venti-
lator settings using polysomnography and monitoring of
SpO2/PtcCO2.
Our approach was as follows: in case of unrewarded
inspiratory efforts, we first reduced pressure support,
then, if necessary, we increased expiratory positive
airway pressure (EPAP) [15] and set expiratory trigger at
a higher percentage of peak inspiratory flow to avoid
delayed cycling [26, 27] under close monitoring of
PtcCO2. When time to peak pressure (pressurisation
time) was set at 100 msec, we increased it by 50–
100 msec. Back-up respiratory rate was increased if
unrewarded inspiratory efforts persisted. Maximal inspi-
ratory time (TIMAX) was calculated in order to maintain a
physiological I/E ratio for COPD patients between 1:2.5
and 1:3.
If auto-triggering was identified, mask fit was adapted to
prevent air leaks and inspiratory trigger sensitivity was
reduced [28]. Inspiratory time (TIMIN) was increased if
double triggering was frequent [13]. Special attention was
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given to mask leaks in order to limit their impact on
patient–ventilator asynchrony.
Statistical analysis
Statistical testing was performed using Prism4 software
(GraphPad, San Diego, CA, USA). When data were
normally distributed (Schapiro–Wilk test), results were
expressed as mean±SD. All variables between the two
nights of the study protocol were compared using a paired t
test. Differences were considered significant when proba-
bility of a type I error was <0.05.
The study protocol was approved by the Ethics Com-
mittee for Medical Research of Geneva University Hospital
and written informed consent was obtained from all
patients. The trial was registered at www.clinicaltrials.gov
(Trial No. NCT01180439)
Results
The study flow chart is depicted in Fig. 1. Among
severe COPD patients treated by our outpatients clinic, 9/
32 (28%) exhibited ‘deventilation dyspnea’ and fulfilled
inclusion criteria. We included eight consecutive COPD
patients (aged 61±8.3 years, three males, five females,
on NIV for 14.3±12.5 months), admitted for a scheduled
routine control of their nocturnal ventilation (n=4 on
VPAP ST III, n=4 on VPAP IV bi-level ventilators;
ResMed, Sydney, Australia) between October 2009 and
March 2010. One patient declined. Patients’ main
characteristics are shown in Table 1. All patients used
their ventilator more than 4 h per night (Mean±SD9:06±
3:20 hours) and suffered from severe morning dyspnea
after interrupting their NIV (referred to as ‘deventilation
dyspnea’).
Ventilator settings at baseline and adjustments under PSG
Baseline ventilator settings and settings after adjustment
under PSG are shown in Table 2. Seven patients used
full-face masks and one patient used a nasal interface.
The major change performed in order to decrease
unrewarded inspiratory efforts detected on PSG, was a
decrease in pressure support in all cases ([IPAP–EPAP]
baseline, 13.6±1.8 cm H2O; adjusted, 10.3±1.7 cm H2O;
p=.0005). In seven cases, IPAP was reduced by 1–5 cm
H2O. In four cases, EPAP was also increased by 1–4 cm
H2O. Back-up rate was increased in four cases. Time to
peak was slightly increased in all cases by 50–100 msec.
TIMAX was adjusted to obtain a I/E ratio between 1:2.5
and 1:3.
Sleep structure and respiratory events under NIV
Unrewarded inspiratory efforts were the most prevalent
patient–ventilator asynchrony. PVA index was reduced
after ventilator adjustment from 40.5±31.0 to 6.7±
7.3%, p=0.009 (Fig. 2). Neither double triggering nor
auto-triggering were identified during both nights. Fig-
Fig. 1 Study flow chart
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ure 3 shows a representative correction of unrewarded
inspiratory efforts by NIV adjustment under sleep
polygraphy.
Neither total sleep time (TST 445±126 vs. 448±
96 min), wake after sleep onset (WASO 41±21 vs. 41±
24 min), nor micro arousal index (MAI 18±9 vs. 20±12 h)
were altered by changes in ventilator settings.
Subjective assessment
The major impact of ventilator adjustment was a marked
decrease in morning dyspnea measured by an adapted Borg
Scale (values from 0 to 10, increasing values mean
increasing dyspnea), for all subjects as shown in Fig. 3
(5.8±2.5 vs. 2.3±1.6, p=0.006).
Table 1 Patients main characteristics
Patients Age Gender Ventilated for (months) FEV1 (% predicted) TLC (% predicted) RV (% predicted)
1 56 M 39 25 120 240
2 62 M 4 21 124 217
3 58 F 3 30 130 231
4 65 F 3 23 129 222
5 52 M 10 28 118 213
6 79 F 14 39 154 228
7 62 F 17 30 111 185
8 55 F 24 47 108 147
Mean 61 14.3 30.4 124.2 210.4
SD 8 12.5 8.7 14.3 30.4
Table 2 Ventilator settings before and after adjustment under PSG
Patients IPAP (cmH2O) EPAP (cmH2O) Pressure support (cmH2O) Back-up rate (/min) Time to peak (ms) TIMAX (s)
Initial ventilator settings
1 22 5 17 13 100 1.2
2 18 6 12 14 100 1.2
3 18 6 12 14 100 1.2
4 19 5 14 14 100 1.2
5 16 4 12 12 100 1.5
6 19 4 15 14 100 1.4
7 18 5 13 14 100 1.1
8 22 8 14 14 100 1.3
Mean 19 5.4 13.6 13.6 100 1.26
SD 2.1 1.3 1.8 0.7 0 0.13
Adjusted ventilator settings
1 17 5 12 13 200 1.2
2 17 6 12 14 200 1.1
3 14 5.4 8.6 14 150 1.3
4 15 6 9 19 150 1.1
5 14 6 8 16 150 1.1
6 16 4 12 14 150 1.4
7 18.6 9 9.6 19 200 1.1
8 20 9 11 17 200 1.2
Mean 16.5* 6.3*** 10.3** 15.8*** 175** 1.19***
SD 2.1 1.8 1.7 2.4 26.7 0.11
FEV1 Forced expiratory volume in 1 s, TLC total lung capacity, RV residual volume, IPAP inspiratory positive airway pressure, EPAP expiratory
positive airway pressure, RR respiratory rate, TIMAX maximal inspiratory time
*p=0.04; **p<0.0005; ***p = NS, P values for paired t tests comparing baseline vs. adjusted ventilator settings
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The eigh-point VAS also showed significant improve-
ments for perception of patient–ventilator synchronisation
(p=0.04), perception of leaks (p=0.04) and overall quality
of sleep (p=0.01) (Fig. 4). None of the VAS scales
decreased (i.e. worsened).
Data provided by ventilator built-in software
Changes in estimated tidal volume (VT), total ventilation
(VE), spontaneous respiratory rate (RR) and percentage of
inspiratory cycles triggered by the patient are reported in
Table 3. Ventilation pattern changed after adjusting ventilator
parameters, with a significant decrease in VT, and increase in
spontaneous RR. The increase in percentage of inspiratory
cycles triggered by the patient most probably reflects a better
patient–ventilator synchronisation and improved detection of
inspiratory efforts by the ventilator [12]. Average leaks were
low during both recordings for all patients with a nonsignif-
icant trend for lower leaks (95% percentile) after adjusting
ventilator settings (28±25 vs. 17±19 L/min, p=0.057).
Nocturnal SpO2 and nocturnal/daytime CO2 values
Mean nocturnal SpO2 was 92±3% on the first night and 91±
2% after adjustment of settings under PSG (p value NS).
Oxygen desaturation index was low and did not differ
Fig. 2 Patient–ventilator asynchrony index (PVA index: total time
spent with unrewarded efforts/total sleep time) for each patient before
and after NIV adjustment with polysomnography
Fig. 3 a Example of
unrewarded inspiratory efforts
with initial ventilator settings.
From top to bottom—flow,
pressure, diaphragm EMG,
thoracic and abdominal belts.
This 60-s epoch shows major
patient–ventilator asynchrony.
Unrewarded efforts can easily
be identified by comparing the
EMG trace or that of the
abdominal and thoracic belts
with the flow or pressure traces.
The patients’ inspiratory efforts
do not trigger the ventilator
which is on its back-up rate.
b Correction of
patient–ventilator asynchrony by
adjustment of ventilator settings
with polysomnography
(60-s epoch). Flow, pressure,
diaphragm EMG and abdominal
and thoracic belts are perfectly
synchronised. All inspiratory
efforts trigger the ventilator
resulting in an increased
respiratory rate
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Fig. 4 Correction of
deventilation dyspnea by
adjusting ventilator settings with
polysomnography is illustrated
for each individual patient on a
modified Borg scale (a, upper
left). On a 0–10 visual analogue
scale, subjective assessment of
ventilator synchronisation (b),
leaks (c) and overall quality of
sleep (d) all improved
Table 3 Data downloaded from ventilator software, transcutaneous capnography and arterial blood gases: baseline values and values after
adjusting ventilator parameters
Patients VT (ml) RR (/min) VE (l/min) Percent (%) of spontaneous inspirations PtcCO2 (kPa) PaCO2 (kPa)
Initial ventilator settings
1 850 16 13.8 52 7.7 6.5
2 660 14 7.6 36 6.7 5.7
3 410 17 6.3 9 6.9 7.6
4 650 15 8.2 7 6.6 8.4
5 650 12 10 31 9.6 10
6 650 14 8 25 6.3 6.9
7 350 21 10.8 90 8.9 8.4
8 600 17 8.1 90 7.4 7.6
Mean 603 15.8 9.1 43 7.5 7.6
SD 157 2.7 2.4 33 1.2 1.3
Adjusted ventilator settings
1 450 26 13.2 96 8.6 6
2 380 18 7.3 86 6.8 5.8
3 340 20 7 40 6.8 6.9
4 480 21 6.2 63 6.8 7.9
5 350 17 9.4 46 8.8 10.5
6 500 18 7.8 85 6.4 6.5
7 350 20 11 63 7.8 7.7
8 600 17 8.1 40 6.4 7.1
Mean 431* 19.6** 8.8*** 65*** 7.3*** 7.3***
SD 93 3 2.3 22 1 1.5
VT Tidal volume, RR respiratory rate, VE minute ventilation, PtcCO2 transcutaneous CO2, PaCO2 morning arterial CO2 under NIV
*p=0.01; **p=0.02; ***p = NS, P values for paired t tests comparing baseline vs. adjusted ventilator settings
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between both nights (3.8±6.0 vs. 3.5±2.9, p value NS).
Despite a significant reduction in pressure support after
adjusting ventilator settings, mean PtcCO2 decreased slightly
although not significantly (7.5±1.2 vs. 7.3±1.0 kPa). Aver-
age morning PaCO2 under NIV also decreased after
adjustment of ventilator settings (7.6±1.3 vs. 7.3±1.5 kPa,
p=0.057).
Discussion
Among severe COPD patients treated at home by NIV,
nearly one third complained of ‘deventilation dyspnea’. Our
study shows in this population that a very high rate of
patient–ventilator asynchrony may occur (mainly unreward-
ed inspiratory efforts) and remain undetected without PSG.
Adjusting ventilator settings after monitoring of nocturnal
NIV by PSG can: (1) improve markedly patient–ventilator
synchronisation, particularly triggering of ventilator; (2)
improve patient comfort; (3) lead to a marked decrease in
morning ‘deventilation dyspnea’; (4) change ventilation
pattern to a more physiological mode for severe COPD, i.e.
increase spontaneous respiratory rate with a slight decrease
in tidal volume, without any deterioration of PaCO2 or
PtcCO2.
The observation that a high rate of unrewarded efforts
occurred and was undetected in these patients confirms
previous observations showing a high rate of patient–
ventilator asynchrony in stable patients under NIV, most
often not reported by the patient [10, 11, 14]. Although
systematic polysomnography is clearly not warranted in
stable patients under NIV, in these eight cases, PSG was
indicated by the importance of morning deventilation
dyspnea and the modest impact of NIV on PtcCO2 [12].
Adjusting ventilator settings had a nonsignificant impact on
arterial blood gases, but a marked effect on patient comfort,
patient–ventilator synchrony and morning dyspnea. Wheth-
er these changes are relevant as major endpoints of NIV is
debatable, but it seems reasonable to assume that these
improvements may have an impact on quality of life and
acceptance of treatment. Indeed, morning deventilation
dyspnea is a source of important discomfort and distress
in these patients.
It may be objected that correction of alveolar hypoventi-
lation in our patients was insufficient. Indeed, both morning
arterial blood gases and nocturnal capnography show a
residual hypercapnia. Recent publications by Windisch et al.
suggest that normalising PaCO2 under NIV may be an
important goal, through the use of high levels of pressure
support and high back-up respiratory rates: this approach
was shown to be feasible, to improve daytime PaCO2,
daytime dyspnea, HRQL and FEV1 [6, 29, 30]. The use of
high-intensity ventilation and its application in clinical
practice still remains a subject of debate. Indeed, several
publications on long-term NIV in COPD have used much
lower insufflation pressures [2–5]. In our centre, our aim is
to obtain the best compromise between reduction of PaCO2/
PtcCO2, induced leaks and patient tolerance. Thus, for all
patients, initial settings of pressure support were as high as
tolerated. Residual hypercapnia in very severe COPD treated
by NIV is frequently reported. All patients included in our
study had severe COPD according to GOLD criteria, had
had several exacerbations with acute hypercapnic respiratory
failure, and had a baseline PaCO2 >7.3 kPa.
The mechanisms suggested for the relationship between
nocturnal PSG findings and ‘deventilation dyspnea’ are
hypothetical and probably differ according to the underlying
pathology. In selected subjects with severe COPD and static
hyperinflation, excessive pressure support might lead to
dynamic hyperinflation and increased PEEPi [31] which are
major determinants of unrewarded efforts [21]. Dynamic
hyperinflation has been shown to correlate strongly with
exercise-induced dyspnea in COPD [32] and may explain the
importance of ‘deventilation dyspnea’. Therefore, patient–
ventilator asynchrony may, in these subjects, be a marker of
inappropriate ventilator settings as demonstrated in the acute
setting [26]. Arguments in favour of such a mechanism are—
in the patients studied—severity of bronchial obstruction and
the presence of static air trapping which may curtail the
patients’ ability to take in large tidal volumes on NIV
without developing dynamic hyperinflation (Table 1). How-
ever, the setting of this study did not allow performing serial
measurements of inspiratory capacity after cessation of NIV;
furthermore, PEEPI could not be estimated non-invasively.
NIV can thus be considered as a two-edged sword in severe
COPD. On one hand, Diaz et al. have shown that efficient NIV
may decrease residual volume, functional residual capacity and
total lung capacity when compared to sham NIV [33]. On the
other hand, inappropriately high pressure support may have in
certain patients a negative impact on lung mechanics and
increase unrewarded efforts and patient–ventilator asynchrony
[26]. Finding the best compromise between too high pressure
support (with patient–ventilator asynchrony), efficacy of
ventilation and patient comfort under monitoring by polyg-
raphy or PSG might be a relevant clinical target.
Limitations of this study are its non-blinded and non-
randomised design. The sequence of night sleep studies were
dictated by necessity of a pragmatic step-by-step assessment:
the first night to identify patient–ventilator asynchrony during
sleep, the second to correct them under appropriate monitor-
ing. As patients were long-time NIVusers, the first night effect
on sleep quality can be considered as negligible. Moreover,
ineffective efforts are objective measurements not influenced
by randomization. Thus, we believe that the initial PSG
reliably reflected patient–ventilator interactions at home. The
advantage of our study design was to validate an effective and
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feasible procedure for NIV adjustment in clinical practice for
COPD complaining from ‘deventilation dyspnea’. The sample
size is another limitation of our study. This may have precluded
the demonstration of significant improvements in objective
sleep quality which is suggested by nearly significant increases
in sleep efficiency (69±18% vs. 76±13%, n.s.) and slowwave
and REM sleep (% N3+REM 29±12% vs. 38±14%, n.s.).
In summary, this study shows that in a selected group of
stable severe COPD with hyperinflation treated by NIV,
patient–ventilator asynchrony and ineffective inspiratory
efforts are frequent, most probably increasing work of
breathing and decreasing the efficacy of ventilation; this
observation may explain the occurrence of morning
deventilation dyspnea. After a diagnostic PSG or polyg-
raphy, adjusting ventilator settings may lead to a significant
decrease of ineffective inspiratory efforts and a significant
improvement of patient comfort during and after NIV.
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